| Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia XS Puente, M Pinyol, V Quesada, L Conde, GR Ordóñez, N Villamor, ... Nature 475 (7354), 101-105, 2011 | 1873 | 2011 |
| Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia V Quesada, L Conde, N Villamor, GR Ordóñez, P Jares, L Bassaganyas, ... Nature genetics 44 (1), 47-52, 2012 | 1234 | 2012 |
| Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features D Sia, Y Jiao, I Martinez-Quetglas, O Kuchuk, C Villacorta-Martin, ... Gastroenterology 153 (3), 812-826, 2017 | 750 | 2017 |
| Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial R Pinyol, R Montal, L Bassaganyas, D Sia, T Takayama, GY Chau, ... Gut 68 (6), 1065-1075, 2019 | 224 | 2019 |
| Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma R Montal, D Sia, C Montironi, WQ Leow, R Esteban-Fabró, R Pinyol, ... Journal of hepatology 73 (2), 315-327, 2020 | 197 | 2020 |
| The role of exome sequencing in newborn screening for inborn errors of metabolism AN Adhikari, RC Gallagher, Y Wang, RJ Currier, G Amatuni, ... Nature medicine 26 (9), 1392-1397, 2020 | 160 | 2020 |
| Trunk mutational events present minimal intra-and inter-tumoral heterogeneity in hepatocellular carcinoma S Torrecilla, D Sia, AN Harrington, Z Zhang, L Cabellos, H Cornella, ... Journal of hepatology 67 (6), 1222-1231, 2017 | 150 | 2017 |
| Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials R Montal, C Andreu-Oller, L Bassaganyas, R Esteban-Fabró, S Moran, ... British journal of cancer 121 (4), 340-343, 2019 | 71 | 2019 |
| Unconventional secretion of FABP4 by endosomes and secretory lysosomes J Villeneuve, L Bassaganyas, S Lepreux, M Chiritoiu, P Costet, J Ripoche, ... Journal of Cell Biology 217 (2), 649-665, 2018 | 71 | 2018 |
| CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications S Franch-Expósito, L Bassaganyas, M Vila-Casadesús, ... elife 9, e50267, 2020 | 54 | 2020 |
| Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis L Bassaganyas, S Beà, G Escaramis, C Tornador, I Salaverria, L Zapata, ... Leukemia 27 (12), 2376-2379, 2013 | 47 | 2013 |
| Copy-number alteration burden differentially impacts immune profiles and molecular features of hepatocellular carcinoma L Bassaganyas, R Pinyol, R Esteban-Fabró, L Torrens, S Torrecilla, ... Clinical Cancer Research 26 (23), 6350-6361, 2020 | 42 | 2020 |
| Whole exome and whole genome sequencing with dried blood spot DNA without whole genome amplification L Bassaganyas, G Freedman, D Vaka, E Wan, R Lao, F Chen, M Kvale, ... Human mutation 39 (1), 167-171, 2018 | 35 | 2018 |
| New factors for protein transport identified by a genome-wide CRISPRi screen in mammalian cells L Bassaganyas, SJ Popa, M Horlbeck, C Puri, SE Stewart, F Campelo, ... Journal of Cell Biology 218 (11), 3861-3879, 2019 | 34 | 2019 |
| PeSV-Fisher: identification of somatic and non-somatic structural variants using next generation sequencing data G Escaramís, C Tornador, L Bassaganyas, R Rabionet, JMC Tubio, ... PLoS One 8 (5), e63377, 2013 | 28 | 2013 |
| Evolutionary dynamics of the Ty3/gypsy LTR retrotransposons in the genome of Anopheles gambiae JMC Tubio, M Tojo, L Bassaganyas, G Escaramis, IV Sharakhov, ... PLoS One 6 (1), e16328, 2011 | 20 | 2011 |
| Golgi enzymes do not cycle through the endoplasmic reticulum during protein secretion or mitosis J Villeneuve, J Duran, M Scarpa, L Bassaganyas, J Van Galen, ... Molecular biology of the cell 28 (1), 141-151, 2017 | 16 | 2017 |
| Worldwide population distribution of the common LCE3C-LCE3B deletion associated with psoriasis and other autoimmune disorders L Bassaganyas, E Riveira-Muñoz, M García-Aragonés, JR González, ... BMC genomics 14, 1-11, 2013 | 15 | 2013 |
| Elongin C (ELOC/TCEB1)-associated von Hippel–Lindau disease A Andreou, B Yngvadottir, L Bassaganyas, G Clark, E Martin, J Whitworth, ... Human molecular genetics 31 (16), 2728-2737, 2022 | 13 | 2022 |
| Molecular predictors of recurrence prevention with sorafenib as adjuvant therapy in hepatocellular carcinoma: Biomarker study of the STORM phase III trial R Pinyol, R Montal, T Takayama, GY Chau, V Mazzaferro, S Roayaie, ... Journal of Hepatology 66 (1), S12-S13, 2017 | 13 | 2017 |
Josep M LlovetProf. of Medicine - Director M Sinai Liver Cancer Prog/ Prof of Research ICREA, BCLC groupVerified email at clinic.cat
